Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.
Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, Corvol H, Cheng SY, Elbert A, Faro A, Goss CH, Gulmans V, Marshall BC, McKone E, Middleton PG, Ruseckaite R, Stephenson AL, Carr SB; Global Registry Harmonization Group. Cosgriff R, et al. J Cyst Fibros. 2020 May;19(3):355-358. doi: 10.1016/j.jcf.2020.04.012. Epub 2020 Apr 25. J Cyst Fibros. 2020. PMID: 32376098 Free PMC article.
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.
McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.
Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.
Sutharsan S, McKone EF, Downey DG, Duckers J, MacGregor G, Tullis E, Van Braeckel E, Wainwright CE, Watson D, Ahluwalia N, Bruinsma BG, Harris C, Lam AP, Lou Y, Moskowitz SM, Tian S, Yuan J, Waltz D, Mall MA; VX18-445-109 study group. Sutharsan S, et al. Among authors: duckers j. Lancet Respir Med. 2022 Mar;10(3):267-277. doi: 10.1016/S2213-2600(21)00454-9. Epub 2021 Dec 20. Lancet Respir Med. 2022. PMID: 34942085 Clinical Trial.
Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.
Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.
Adverse Childhood Experiences (ACEs) in Adults with Cystic Fibrosis.
O'Leary C, Edwards V, Hardcastle KA, McCulloch A, Duckers JM. O'Leary C, et al. Psychol Res Behav Manag. 2022 Jun 28;15:1601-1605. doi: 10.2147/PRBM.S322425. eCollection 2022. Psychol Res Behav Manag. 2022. PMID: 35789731 Free PMC article.
Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised.
Acaster S, Mukuria C, Rowen D, Brazier JE, Wainwright CE, Quon BS, Duckers J, Quittner AL, Lou Y, Sosnay PR, McGarry LJ. Acaster S, et al. Among authors: duckers j. Value Health. 2023 Apr;26(4):567-578. doi: 10.1016/j.jval.2022.12.002. Epub 2022 Dec 9. Value Health. 2023. PMID: 36509366 Free article. Clinical Trial.
BronchUK: protocol for an observational cohort study and biobank in bronchiectasis.
De Soyza A, Mawson P, Hill AT, Elborn S, Bradley JM, Haworth CS, Floto RA, Wilson R, Loebinger MR, Carroll M, Crichton M, Chalmers JD, Sullivan A, Brown J, Hurst JR, Duckers J, Kelly M, Steer J, Gatheral T, Walker PP, Winstanley C, McGuire A, Denning D, McNally R. De Soyza A, et al. Among authors: duckers j. ERJ Open Res. 2021 Apr 19;7(2):00775-2020. doi: 10.1183/23120541.00775-2020. eCollection 2021 Apr. ERJ Open Res. 2021. PMID: 33898620 Free PMC article.
The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
Adeloye D, Elneima O, Daines L, Poinasamy K, Quint JK, Walker S, Brightling CE, Siddiqui S, Hurst JR, Chalmers JD, Pfeffer PE, Novotny P, Drake TM, Heaney LG, Rudan I, Sheikh A, De Soyza A; International COVID-19 Airways Diseases Group. Adeloye D, et al. Lancet Respir Med. 2021 Dec;9(12):1467-1478. doi: 10.1016/S2213-2600(21)00286-1. Epub 2021 Aug 17. Lancet Respir Med. 2021. PMID: 34416191 Free PMC article. Review.
Development of a Simple and Robust Whole Blood Assay with Dual Co-Stimulation to Quantify the Release of T-Cellular Signature Cytokines in Response to Aspergillus fumigatus Antigens.
Lauruschkat CD, Page L, White PL, Etter S, Davies HE, Duckers J, Ebel F, Schnack E, Backx M, Dragan M, Schlegel N, Kniemeyer O, Brakhage AA, Einsele H, Loeffler J, Wurster S. Lauruschkat CD, et al. Among authors: duckers j. J Fungi (Basel). 2021 Jun 8;7(6):462. doi: 10.3390/jof7060462. J Fungi (Basel). 2021. PMID: 34201183 Free PMC article.
Systemic comorbidities in bronchiectasis.
Gale NS, Bolton CE, Duckers JM, Enright S, Cockcroft JR, Shale DJ. Gale NS, et al. Among authors: duckers jm. Chron Respir Dis. 2012;9(4):231-8. doi: 10.1177/1479972312459973. Chron Respir Dis. 2012. PMID: 23129800 Free article.
Gaining an Understanding of Pneumocystosis in Wales.
Ayling-Smith J, Backx M, Grant E, Dhillon R, Duckers J, Hood K, White PL. Ayling-Smith J, et al. Among authors: duckers j. J Fungi (Basel). 2023 Jun 13;9(6):660. doi: 10.3390/jof9060660. J Fungi (Basel). 2023. PMID: 37367596 Free PMC article.
A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial.
Bradley JM, Anand R, O'Neill B, Ferguson K, Clarke M, Carroll M, Chalmers J, De Soyza A, Duckers J, Hill AT, Loebinger MR, Copeland F, Gardner E, Campbell C, Agus A, McGuire A, Boyle R, McKinney F, Dickson N, McAuley DF, Elborn S; CLEAR study group. Bradley JM, et al. Among authors: duckers j. Trials. 2019 Dec 19;20(1):747. doi: 10.1186/s13063-019-3766-9. Trials. 2019. PMID: 31856887 Free PMC article.
The bulbar conjunctival vascular bed in diabetic chilren.
DITZEL J, DUCKERS J. DITZEL J, et al. Among authors: duckers j. Acta Paediatr (Stockh). 1957 Nov;46(6):535-52. doi: 10.1111/j.1651-2227.1957.tb14482.x. Acta Paediatr (Stockh). 1957. PMID: 13487321 No abstract available.
Perceptions of inspiratory muscle training in adults recovering from COVID-19.
Shelley J, Hudson J, Mackintosh KA, Saynor ZL, Duckers J, Lewis K, Davies GA, Berg RMG, McNarry MA. Shelley J, et al. Among authors: duckers j. PLoS One. 2022 Nov 3;17(11):e0270620. doi: 10.1371/journal.pone.0270620. eCollection 2022. PLoS One. 2022. PMID: 36327314 Free PMC article.
Investigating Pseudomonas aeruginosa population structure and frequency of cross-infection in UK cystic fibrosis clinics - a reference laboratory perspective.
Kenna DTD, Payne Z, Lee DA, Keane AM, Turton J, Zamarreño DV, Schaefer U, Hopkins KL, Meunier D, Dhillon R, Duckers J, Speight L, Turton JF. Kenna DTD, et al. Among authors: duckers j. J Cyst Fibros. 2023 Sep;22(5):894-900. doi: 10.1016/j.jcf.2023.05.017. Epub 2023 Jun 2. J Cyst Fibros. 2023. PMID: 37271666 Free article.
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A; VX18-121-101; VX18-561-101 Study Groups. Uluer AZ, et al. Lancet Respir Med. 2023 Jun;11(6):550-562. doi: 10.1016/S2213-2600(22)00504-5. Epub 2023 Feb 23. Lancet Respir Med. 2023. PMID: 36842446 Free article. Clinical Trial.
VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.
Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM; VX16-659-101 Study Group. Davies JC, et al. N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18. N Engl J Med. 2018. PMID: 30334693 Free PMC article. Clinical Trial.
COPD-bronchiectasis overlap syndrome.
Hurst JR, Elborn JS, De Soyza A; BRONCH-UK Consortium. Hurst JR, et al. Eur Respir J. 2015 Feb;45(2):310-3. doi: 10.1183/09031936.00170014. Eur Respir J. 2015. PMID: 25653262 Free article. No abstract available.